Since the plasma adiponectin level in colorectal adenoma patients is significantly lower than age-, sex-, and body mass index-matched non-cancer controls, it is considered a good biomarker for carcinogenesis and progression of colorectal adenoma [11]. This evidence concerns the gene ADIPOQ and cancer.